Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Lightbridge Completes Loading of Capsules Containing Lightbridge Fuel Material Samples into an Experiment Assembly for Irradiation Testing in the Advanced Test Reactor
-
Caliber Reports Preliminary Third Quarter 2025 Results
-
Garrett Motion to Hold Third Quarter 2025 Financial Results Conference Call on Thursday October 23, 2025
-
Rekor Systems Announces Early Deployments with Caltrans and Texas DOT for Rekor Discover ®, Signaling Scalable Statewide Opportunities
-
Tonix Pharmaceuticals to Present and Participate in Panel Discussion at World Vaccine Congress, Europe 2025
-
NFI schedules third quarter 2025 financial results and conference call
-
Critical Mineral Resource at Falchani Exceeds 400,000 t Cesium (M+Ind) Within Existing Lithium Resource
-
Mobilicom Debuts Industry-First Secured Autonomy Compute System with Aitech NVIDIA-Based AI Supercomputers
-
Fusion Fuel Green PLC Reports New Al Shola Gas Contracts and Announces Expansion into the UAE’s Northern Emirates
-
Plug Participating in Concurrent Non-Deal Roadshows in Paris and Boston
-
Tilray Brands Reports Strong First Quarter Fiscal 2026 Results, Highlighting Continued Growth with Record Q1 Net Revenue of $210 Million and Net Income
-
Amplify ETFs Launches Ethereum Option Income ETFs
-
Rivalry Closes First Tranche of Private Placement
-
Rekor Systems Announces Early Deployments with Caltrans and Texas DOT for Rekor Discover ®, Signaling Scalable Statewide Opportunities
-
Aduro Clean Technologies Advances Demonstration Plant Program; Begins Global Site Selection Project
-
Axsome Therapeutics Recognizes Mental Illness Awareness Week Along with the National Advocacy Community
-
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
-
National Organization on Disability Hosts Landmark Event on Technology, Accessibility, and the Future of Work
-
Barrick to Report Third Quarter 2025 Results on November 10
-
Lehman Brothers UK Capital Funding LP: Notice of Interim Payment
-
Wabash Redefines Trailer Accessibility with Trailers as a Service
-
Rail Vision Signs Term Sheet to Boost Growth with Advanced AI Acquisition of 51% Stake in Quantum Transportation
-
Dr. Mark Hyman joins ADvantage Therapeutics Advisory Board to further advance Klotho-Based Longevity Programs at Klothea Bio
-
Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform
-
Azimut Confirms Extensive High-Grade Lithium Surface Discovery on Wabamisk East Property, James Bay Region, Quebec
-
Baghdadi Capital Group Selects nCino to Power Global Growth and Expansion Strategy
-
Genvor Restores Trading Status and Expands Global Collaborative Research Network
-
Isfayram Hydropower RWA Raises $1 Million On-Chain via PicWe as IHP Market Cap Surpasses $10 Million
-
U.S. FDA approves Boehringer’s JASCAYD® (nerandomilast tablets) as first new treatment option for adults with IPF in over a decade
-
Google’s Diane Tang Receives Joseph Lieberman Award for Outstanding Achievement in STEM at Center for Excellence in Education (CEE) Reception in Washington, DC
-
Young People Worldwide Shape the Future of Climate Policy
-
Form 8.3 - AXA INVESTMENT MANAGERS: Unite Group plc.
-
IREN Prices $875 Million Convertible Notes Offering
-
Akero Therapeutics to be Acquired by Novo Nordisk for up to $5.2 Billion
-
IREN Prices $875 Million Convertible Notes Offering
-
Novo Nordisk to acquire Akero Therapeutics and its promising phase 3 FGF21 analogue to expand MASH portfolio
-
Human Appeal's Pot of Gold Film to Air on EarthX Channel on October 18
-
MEXC Concludes "Race to Zero" Event, Unlocking 1 BTC Prize Pool
-
CTi Welcomes Dr. Luis F. Quintero to Advisory Board, Strengthening Focus on Oil & Gas and Frack & Produced Water
-
METALSOURCE MINING CLOSES PRIVATE PLACEMENT
-
MEXC Concludes "Race to Zero" Event, Unlocking 1 BTC Prize Pool
-
Goranson Bain Ausley Expands Service to Denton County with New Partner Chad Elsey
-
Zymeworks Appoints Dr. Adam Schayowitz as Acting Chief Development Officer
-
Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial
-
Form 8.3 - AXA INVESTMENT MANAGERS: Empiric Student Property Plc
-
Repayments, Realkredit Danmark A/S
-
Form 8.3 - AXA INVESTMENT MANAGERS: PRS REIT Plc
-
Form 8.5 (EPT/RI) - Epwin Group Plc
-
Form 8.5 (EPT/RI) - Greencore Group Plc
-
FERRARI CAPITAL MARKETS DAY TARGETING NEW HEIGHTS
